ZMC(SH:600216)2014-04-25 16:00Financial Performance - Operating revenue for the first quarter was ¥1,236,596,777.69, a decrease of 3.62% compared to the same period last year[10]. - Net profit attributable to shareholders decreased by 48.22% to ¥93,392,145.45[10]. - Basic earnings per share dropped by 48.19% to ¥0.100[10]. - The company forecasts a net profit decline of 40%-60% for the first half of 2014, primarily due to a significant drop in the price of its main product, Vitamin E[20]. - Net profit for the period was CNY 93,145,754.33, down 48.3% from CNY 180,046,299.71 in the previous period[32]. - Basic earnings per share decreased to CNY 0.100 from CNY 0.193, reflecting a decline of 48.9%[33]. Assets and Liabilities - Total assets increased to ¥7,690,820,045.44, up 1.78% from the previous year-end[10]. - The company's total assets as of March 31, 2014, were ¥7,690,820,045.44, an increase from ¥7,556,366,447.97 at the beginning of the year[25]. - Total liabilities increased to ¥1,121,674,752.01 from ¥1,075,944,787.65, reflecting a rise in current liabilities[25]. - Total assets increased to CNY 6,978,190,079.03, compared to CNY 6,878,634,892.21 in the previous period, marking a growth of 1.5%[29]. - Total liabilities rose to CNY 548,254,655.13, an increase of 11.1% from CNY 493,360,800.47[29]. Cash Flow - Cash flow from operating activities showed a net outflow of ¥14,980,136.56, down 134.88% from the previous year[10]. - The company's cash flow from operating activities showed a significant decline, impacting liquidity[36]. - Operating cash inflow for the current period was CNY 1,231,299,185.25, a decrease of 3.9% from CNY 1,281,534,393.38 in the previous period[37]. - Cash outflow from operating activities totaled CNY 1,246,279,321.81, an increase of 0.6% compared to CNY 1,238,581,703.27 in the prior period[38]. - Net cash flow from operating activities was negative CNY 14,980,136.56, a significant decline from positive CNY 42,952,690.11 in the previous period[38]. - Cash inflow from investment activities was CNY 10,343,000.00, slightly up from CNY 10,222,526.00 in the last period[39]. - Cash outflow from investment activities was CNY 179,600,662.09, down 38.8% from CNY 293,565,275.25 in the previous period[39]. - Net cash flow from investment activities was negative CNY 169,257,662.09, an improvement from negative CNY 283,342,749.25 in the prior period[39]. - The ending cash and cash equivalents balance was CNY 1,526,744,421.20, down from CNY 2,247,205,568.23 in the prior period[40]. - The net decrease in cash and cash equivalents for the current period was CNY 183,142,425.21, an improvement from a decrease of CNY 244,624,000.00 in the previous period[40]. Shareholder Information - The number of shareholders reached 77,515, with the top ten shareholders holding a combined 62.77% of shares[14]. Tax and Financial Adjustments - Deferred income tax assets increased by 31.81% to ¥21,810,897.35[17]. - The company is currently in the process of reapplying for high-tech enterprise qualification, affecting the income tax rate[17]. - Financial expenses showed a dramatic decrease of 553.87%, resulting in a cost of -¥12,066,981.78 compared to ¥2,658,674.58 in the previous year[18]. - The impairment loss on assets decreased by 66.16%, amounting to ¥4,685,494.55 compared to ¥13,846,738.02 in the previous year[18]. - Other comprehensive income showed a significant decline of 108.86%, resulting in -¥4,422,121.22 compared to ¥49,912,871.24 in the previous year[18]. Inventory and Receivables - The company's inventory increased slightly to ¥754,754,885.16 from ¥748,515,656.52 at the beginning of the year[23]. - Inventory decreased to CNY 499,487,887.06 from CNY 555,303,177.65, a reduction of 10.1%[28]. - The company reported an increase in accounts receivable to CNY 716,983,091.93, up 19.8% from CNY 598,648,971.24[28]. Future Plans - The company plans to focus on market expansion and new product development in the upcoming quarters[36].